SiriusPointSPNT
Recorded

SiriusPoint 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration56 minParticipants9

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good morning, ladies and gentlemen, and welcome to the SiriusPoint third quarter 2026 earnings conference call. During today's presentation, all parties will be in a listen-only mode. Following the conclusion of prepared remarks, management will host a question-and-answer session, and instructions will be given at that time. As a reminder, this conference call is being recorded, and a replay is available through 11:59 P.M. Eastern Time on November 20, 2026. With that, I would like to turn the call over to Liam Blackledge, Investor Relations and Strategy Manager.

Liam BlackledgeInvestor Relations and Strategy Manager

Please go ahead. Good morning, and thank you for joining us for SiriusPoint's third quarter and nine-month 2026 earnings call.

Liam BlackledgeInvestor Relations and Strategy Manager

Last night, we released our earnings press release, Form 10-Q, and financial supplement, all of which are available on our website at investors.siriuspt.com, along with the slides that will accompany today's discussion. Joining me on the call are Scott Egan, our Chief Executive Officer, and Jim McKinney, our Chief Financial Officer. Before we begin, I'd like to remind you that today's remarks contain forward-looking statements based on current expectations, and actual results may differ materially. We will also reference certain non-GAAP financial measures, which we believe are useful in evaluating the performance of the business. Reconciliations can be found in the presentation and our SEC filings. Please refer to our earnings release and accompanying materials for a more complete discussion of forward-looking statements and non-GAAP measures.

Liam BlackledgeInvestor Relations and Strategy Manager

With that, I'll turn this call over to Scott.

Scott EganCEO

Thanks, Liam, and welcome everyone to our third quarter and nine-month results call. Before I turn to the results, I want to welcome John Sauerland to our board of directors. John brings more than 35 years of insurance industry experience, and I'm sure many of you will know him from his time at Progressive, where he most recently served as Chief Financial Officer. John will be a strong addition to the board, and his appointment speaks to the quality of the business we are building and our ambitions for the future, and I'm really looking forward to welcoming John to SiriusPoint. Turning to the results now, the third quarter saw SiriusPoint deliver another strong performance, with attractive underwriting margins, disciplined growth, and returns above our 12%-15% ROE target range.

Scott EganCEO

We continue to demonstrate the strength of our diversified specialty underwriting portfolio, which is increasingly important as pricing becomes more competitive in multiple lines of business. Our business model and approach to the market is delivering strong premium growth in the places we want it and where we see attractive underwriting margins. The performance this quarter is further evidence of our portfolio mix and deliberate low-volatility strategy delivering for our shareholders. Our stated aim is to deliver a 12%-15% return across the cycle, and this is another quarter where we have exceeded that target and created strong shareholder value. Throughout the nine-month mark, our key takeaways are unambiguous. The business is performing strongly. We are committed to underwriting discipline. We actively and carefully manage our portfolio mix and volatility.

Scott EganCEO

We are growing and have a healthy pipeline of business opportunities, and we have a strong balance sheet and can be agile in our deployment of capital. Jim will take you through the full financials later in the call as usual, but as a brief overview, the third quarter saw us deliver 20% growth in insurance and services and a core combined ratio of 90.1%. Our operating return on equity was 17.6%. Year-to-date, insurance and services have grown by 14%, while overall core growth of 7% reflects our disciplined approach to reinsurance, where we have shrunk premiums by 6%. On a year-to-date basis, our core combined ratio was also 90.1%, and our operating return on equity is 15.8%, above our 12%-15% target range. Book value continues to compound at a strong rate.

Scott EganCEO

Excluding AOCI, our diluted book value per share increased by 4% in the quarter and is now up 12% through the first nine months. Core operating return on equity, which excludes the runoff portfolio result, was 18.1% for the quarter and 17% for the first nine months. This metric becomes increasingly important given today's announcement that we have entered into a loss portfolio transfer agreement with RiverStone that will substantially cover our remaining runoff exposures. The transaction is subject to customary regulatory approvals, and following completion, our runoff exposures will be at de minimis levels. Put simply, this transaction allows us to effectively close the chapter on the legacy book once and for all. The transaction is supported by significant limit and strong collateral, while SiriusPoint will retain some responsibility for claims administration.

Scott EganCEO

As I have previously discussed on these calls, the runoff reserves relate to business written before 2023, prior to when the organization pivoted to its new underwriting strategy. They have been running off and reducing over the past two years, but carry the potential to cause reserve volatility along the way. Since 2024, pure underwriting losses, excluding claims administration expenses, have totaled approximately $60 million for the runoff portfolio. Therefore, we see the mitigation of this uncertainty as a further positive step and one we hope reinforces the earning strength of our go-forward core portfolio, which, as I said earlier, is operating well above our 12%-15% return on equity target. We feel that our reserve position was strong prior to the LPT, reflecting our approach to initially reserving MGAs above pricing projections and a track record of 22 consecutive quarters of favorable prior year releases.

Scott EganCEO

Following the transaction, we feel we are in an even stronger reserving position, as we have removed what we believe is the greatest element of uncertainty. Jim will discuss the expected accounting impact, but importantly, it also frees up capital tied to these legacy reserves of over $200 million on completion and will increase our BSCR ratio by around 20 points. I am sure I will get asked what we plan to do with this capital, and our prioritization remains unchanged. We want to deploy it to support our organic growth where it meets our strict underwriting targets. Beyond that, we will continue to be thoughtful and dynamic in our approach to capital management, returning excess capital to shareholders when appropriate.

Scott EganCEO

This can be seen by our track record, where we have returned $300 million of capital in 2026 alone, on top of the $1 billion of capital returned from strategic capital actions between 2024 and 2025. In line with the established practice we have set out, we expect to provide an update on our capitalization levels and capital return program in the fourth quarter earnings call following the closeout of 2026 and the completion of our 2027 planning process. In the meantime, we will continue with our current buyback program, which we set out earlier in the year. What is clear is that our balance sheet, capital strength, and agility have never been higher or stronger, and that is a good thing for all stakeholders.

Scott EganCEO

Looking at slide 11, where we show our core operating ROE metric, as I noted earlier, this becomes a more important metric as we think about the business performance going forward post the LPT, and one that we introduced at the beginning of this year with this evolution in mind. By reducing the earnings drag associated with the legacy book, the LPT should drive greater alignment between our core operating ROE and operating ROE on a go-forward basis. There will still be claims administration and related expenses for a period while it runs off. Our core operating ROE has exceeded our 12%-15% target for the past two years and is above again for the first nine months of this year. The LPT transaction reinforces the company's ability and confidence to meet or outperform that range going forward.

Scott EganCEO

Looking briefly at slide seven, our track record for both earnings and value creation is strong and consistent. Operating earnings per share continue to grow and are up 19% in the third quarter and 17% year to date versus the prior year. On the back of this, our book value per share continues to compound at a healthy rate, with a compound annual growth rate of 19% over the last three years. We have grown book value per share by 12% just in the first nine months, reinforcing that trajectory. These numbers demonstrate a momentum and a consistency which I believe validates our strategy and approach to building a diversified portfolio that targets discipline and sustainable growth. Slide 12 talks to this portfolio and illustrates the scale and breadth of our specialty platform, the meaningful positions we have across multiple lines, and our active management of the various pricing cycles.

Scott EganCEO

Importantly, where we are growing and where we are reducing exposure is consistent with the market conditions we have been describing to you and those evident across the broader market. We do not need to maintain positions in lines where returns do not adequately compensate for the risk taken. We have other opportunities to deploy our capital more attractively. You can see this in action with solid growth in A&H, surety, and pockets of P&C insurance lines, while we are reducing premiums in aviation and property cat reinsurance. We are not afraid to either lean in or lean out in specific markets, and Jim will provide more color in each of the specialties later in the call. We also want to outline our plans today to update our segment reporting beginning in the fourth quarter.

Scott EganCEO

Since 2022, we have changed significantly and have evolved from our roots as a Bermudian reinsurer into a specialty underwriter with a strong insurance focus anchored around key specialty lines of business. Increasingly, these specialties reflect how we discuss and manage the portfolio today, dynamically balancing market conditions and mix to deliver low volatility outcomes for the total portfolio, which we are clear drives the best value creation for shareholders. We think our financial reporting should reflect that evolution, so beginning in the fourth quarter, we expect to update our financial reporting segments to better reflect the evolution of the business and how we manage the company. A&H, our largest specialty line, writing over $1 billion of premium, becomes a standalone segment. A&H is strategically important to SiriusPoint, given its track record of profitability, low correlation with P&C market cycles, and relatively low capital intensity.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day